Indaptus Therapeutics, Inc.
INDP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001857044
No open-market purchases or sales by Indaptus Therapeutics, Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $1.15M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Indaptus Therapeutics, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 21 | 18 | −3 |
| Shares | 599.9K | 605.0K | +5.11K (+0.9%) |
| Value | $1.26M | $750.2K | −$512.1K (−40.6%) |
New holders (1)
Institutions that held Indaptus Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Danske Bank A/S | 1 | $1 | 0.00% |
Sold out (4)
Institutions that held Indaptus Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Beaird Harris Wealth Management, LLC | 300 | $636 |
| FMR LLC | 79 | $167 |
| Massmutual Trust Co FSB | 14 | $30 |
| Qube Research & Technologies Ltd | 1 | $2 |